metallodrugs

Term used to define a pharmaceutical, having a activity center containing a metal. Platinum (cisplatin, carboplatin) and gold (Auranofin) compounds are well-known in cancer therapy whereas some other gold compounds (aurithiomalate, aurothioglucose) are important antiarthritic drugs. A wide range of Tc compounds (e.g. Tc-labelled antibodies, Tc-mercaptoacetyl glycine complex) are used for diagnostic imaging of renal, cardiac and cerebral functions and of various forms of cancer. Gadolinium (III) polyaminopolycarboxylic crown complexes are widely used as contrast agents in magnetic resonance imaging.



The term "metallodrugs" was found in the following pages:

New Studies Question Safety of MRI Contrast Agents | EVISA's News
Side effects of cisplatin chemotherpy: Platinum speciation matters | EVISA's News
Special issue on "Advances in speciation techniques and methodology" available | EVISA's News
Books and Special Issues on Elemental Speciation (published since 2006) | EVISA's News
Gadolinium-based contrast agents induce gadolinium deposits in cerebral vessel walls | EVISA's News
Vaccine ingredient causes brain damage; some nutrients prevent it | EVISA's News
EMA Issues Final Opinion Limiting Gadolinium Contrast Agents in Body Scans | EVISA's News
Directory of scientists: Michael Sperling
Copper molecule shows promise in fighting against cancer | EVISA's News
Books and Special Issues on Elemental Speciation (published since 2011) | EVISA's News
Directory of scientists: Jürgen Gailer
Journals database: Metallomics
Link database: Italy: Interdepartmental Research Center “Role of Metal Ions in Biomedical Sciences - BIOMÉTION”
Quantification of Technetium-99 in Wastewater Using Online Preconcentration and Anion-Exchange Chromatography Coupled with Inductively Coupled Plasma-Mass Spectrometry | EVISA's News
Tracing Gadolinium-based Contrast Agents from Wastewater, via Surface Water to Drinking Water | EVISA's News
Toxicity of organomercury compounds | EVISA's News
European Medicines Agency recomments to pull linear Gadolinium-based MRI contrast agents from market | EVISA's News
The retention of gadolinium in the human body following the use of gadolinium-based MRI contrast agents: a call to action for analytical chemists | EVISA's News
Link database: Australia: University of Sydney: Group of Peter A. Lay
Combined speciation analysis and elemental bioimaging provides new information about the retention of gadolinium in kidney following the application of some MRI contrast agents | EVISA's News